TB Archives – Treatment Action Group

Treatment Action Group Statement on Bedaquiline Unaffordability

July 6, 2020
Dorrit Walsh

Treatment Action Group welcomes the Global Drug Facility / Stop TB Partnership's negotiation of what amounts to a 32% savings on bedaquiline, the backbone of improved, all-oral regimens for treating drug-resistant TB.

2020 Pipeline Report

July 2, 2020
Dorrit Walsh

Pipeline Report provides an overview of research and provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).

Treatment Action Group Commemorates Juneteenth through Solidarity Actions, Reflection, and Transparency

June 18, 2020
Dorrit Walsh

Tomorrow, Treatment Action Group (TAG) will be observing and honoring Juneteenth—a commemoration of the end of slavery in the United States—through a day of solidarity, actions, and reflection.

Podcast with Dr. Madhukar Pai: TB Diagnostics Advocacy in the Context of COVID-19

June 12, 2020
Dorrit Walsh

On this podcast, Dr. Madhukar Pai describes the ways that the COVID-19 pandemic has delayed and limited access to TB diagnostic testing, and how all stakeholders must step-up efforts to mitigate these impacts and ensure that TB diagnostic testing is not abandoned in the response to COVID-19.

2019 Annual Report

June 9, 2020
Dorrit Walsh

2019 was a year of significant progress against HIV, tuberculosis (TB), and hepatitis C virus (HCV). We shaped policy and legislation to end these conditions, secured increased funding to do so at various levels of government, and stood up for the rights of affected communities.

Treatment Action Group Mourns and Resists Violence towards Black Communities; Demands Action and Accountability across Government and Systems

June 5, 2020
Dorrit Walsh

Treatment Action Group (TAG) joins partners, activists, and communities around the U.S. and the world in decrying violence against Black people and those who stand in solidarity with them.

SARS-CoV-2 Serological Testing: What Is It and What Does It Mean?

May 13, 2020
Dorrit Walsh

ICAP at Columbia, TAG, and the COVID-19 Working Group – New York presented this webinar on May 13, 2020.

AVAC and TAG Statement on Ethical Conduct of SARS-CoV-2 Vaccine Challenge Studies

May 7, 2020
Dorrit Walsh

The COVID-19 pandemic is a global health emergency that may demand new, safe, and expedited ways of conducting ethical research to find the solutions we need, including a safe and effective vaccine.

TAGline May 2020

May 6, 2020
Dorrit Walsh

Realizing the Right to Science: When we started to put together this issue of TAGline, we had no idea that COVID-19 was about to make its appearance and wreak havoc on every country of the world.

Treatment Action Group and the PrEP4All Collaboration Respond to Reported Remdesivir Results for COVID-19

April 30, 2020
Dorrit Walsh

Treatment Action Group (TAG) and the PrEP4All Collaboration welcome results from randomized controlled trials of therapies for COVID-19, but are seriously concerned about claims that data from a National Institutes of Allergy and Infectious Diseases (NIAID) study of the Gilead drug remdesivir...